5 results
pharmacology dm2 management comparison diagnosis dka dosing eudka euglycemic inhibitors inpatient mellitus renal table
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Action for Common Diabetes ... Receptor Agonists • DPP4i ... sarahthelyon #Diabetes ... #pathophysiology ... #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... different than other medications ... very tolerable medication ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... confusion coma #DiabeticKetoacidosis ... #DKA #pathophysiology ... #endocrinology ... #diabetes
No results found for "Myeloblast basophils pathophysiology endocrinology adrenal diabetes diabetic ketoacidosis medications dpp4 diabeticketoacidosis"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Myeloblast #basophils #pathophysiology #endocrinology #adrenal #diabetes #diabetic #ketoacidosis #medications #dpp4 #diabeticketoacidosis